# AbbVie Inc.: Form 8-K, filed Sep 3, 2026

- Company: [AbbVie Inc.](/companies/abbv.md) (CIK 1551152)
- Form: 8-K
- Filed: 2026-09-03
- Accepted by EDGAR: Sep 3, 2026, 08:47 ET
- Period: 2026-09-03
- Accession: 0001104659-26-104940
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1551152/000110465926104940/tm2624674d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1551152/000110465926104940/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1551152/000110465926104940/tm2624674d1_8k.htm

Filed Sep 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-104940. Last ingested by Listed: Nov 3, 2026, 15:34 ET. No prices; not investment advice.